Prime Medicine, Inc.
PRMEHealthcareBiotechnology
市值
$699.0M
CEO
Allan Reine
员工数
214
行业
Biotechnology
上市日期
2022-10-20
收录人数
15
近期高管变动
04/16上任Svetlana Makhni Chief Financial Officer and Principal Financial Officer07/15离任Jeremy Duffield, M.D. Ph.D., FRCP Chief Scientific Officer05/19resignedKeith Gottesdiener, M.D. President, Chief Executive Officer, Principal Executive Officer, Member of the Board of Directors, and all other officer and director positions held with Prime Medicine, Inc. and its subsidiaries01/05上任Allan Reine Chief Financial Officer and Principal Financial Officer05/11上任Jeff Marrazzo Class II Director, Member of the Compensation Committee
K
Keith Gottesdiener2家
See Remarks
董事高管
A
Allan Reine
Chief Executive Officer
董事高管
D
David Schenkein3家
董事
董事
M
Michael Kelly3家
董事
董事
K
Kaye Foster-cheek2家
董事
董事
R
Robert Nelsen2家
董事
董事
W
Wendy Chung2家
董事
董事
J
Jeffrey Marrazzo
董事
董事
T
Thomas Cahill
董事
董事